 Nancy Krebs
Concepts (712)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Zinc | 111 | 2025 | 297 | 15.940 |
Why?
| | Infant Nutritional Physiological Phenomena | 41 | 2025 | 144 | 9.480 |
Why?
| | Dietary Supplements | 58 | 2025 | 559 | 7.950 |
Why?
| | Nutritional Status | 43 | 2025 | 344 | 6.240 |
Why?
| | Micronutrients | 27 | 2025 | 92 | 5.690 |
Why?
| | Milk, Human | 33 | 2023 | 158 | 5.640 |
Why?
| | Developing Countries | 76 | 2025 | 306 | 5.560 |
Why?
| | Maternal Nutritional Physiological Phenomena | 17 | 2025 | 176 | 5.500 |
Why?
| | Breast Feeding | 52 | 2025 | 439 | 5.470 |
Why?
| | Diet | 62 | 2025 | 1274 | 5.130 |
Why?
| | Infant Food | 25 | 2025 | 65 | 4.210 |
Why?
| | Intestinal Absorption | 37 | 2022 | 102 | 4.030 |
Why?
| | Meat | 13 | 2021 | 94 | 3.980 |
Why?
| | Infant | 155 | 2025 | 9398 | 3.570 |
Why?
| | Child Development | 21 | 2024 | 464 | 3.520 |
Why?
| | Premature Birth | 23 | 2023 | 331 | 3.350 |
Why?
| | Iron | 21 | 2025 | 312 | 3.280 |
Why?
| | Pregnancy Outcome | 31 | 2025 | 412 | 3.280 |
Why?
| | Nutritional Requirements | 25 | 2019 | 78 | 3.170 |
Why?
| | Infant, Newborn | 117 | 2025 | 6033 | 2.970 |
Why?
| | Infant Mortality | 36 | 2023 | 116 | 2.910 |
Why?
| | Preconception Care | 11 | 2025 | 43 | 2.900 |
Why?
| | Pregnancy | 132 | 2025 | 6728 | 2.860 |
Why?
| | Phytic Acid | 19 | 2017 | 42 | 2.790 |
Why?
| | Anemia, Iron-Deficiency | 11 | 2025 | 58 | 2.610 |
Why?
| | Growth Disorders | 12 | 2022 | 86 | 2.570 |
Why?
| | Food, Fortified | 20 | 2025 | 41 | 2.570 |
Why?
| | Iron, Dietary | 9 | 2019 | 22 | 2.450 |
Why?
| | Infant Formula | 11 | 2023 | 75 | 2.380 |
Why?
| | Guatemala | 38 | 2025 | 326 | 2.340 |
Why?
| | Perinatal Death | 13 | 2023 | 25 | 2.320 |
Why?
| | Child Health | 20 | 2023 | 154 | 2.270 |
Why?
| | Stillbirth | 25 | 2023 | 72 | 2.260 |
Why?
| | Female | 263 | 2025 | 72787 | 2.160 |
Why?
| | Prenatal Care | 23 | 2025 | 288 | 2.140 |
Why?
| | Poverty | 13 | 2023 | 520 | 2.040 |
Why?
| | Humans | 341 | 2025 | 136764 | 2.030 |
Why?
| | Obesity, Morbid | 7 | 2021 | 259 | 1.950 |
Why?
| | Fetal Development | 7 | 2025 | 296 | 1.910 |
Why?
| | Cesarean Section | 8 | 2021 | 183 | 1.850 |
Why?
| | Dairy Products | 3 | 2021 | 36 | 1.840 |
Why?
| | Homeostasis | 21 | 2015 | 619 | 1.830 |
Why?
| | Obesity | 24 | 2024 | 2982 | 1.820 |
Why?
| | Infant Health | 10 | 2023 | 25 | 1.810 |
Why?
| | Lactation | 15 | 2024 | 181 | 1.790 |
Why?
| | Feces | 27 | 2025 | 483 | 1.760 |
Why?
| | Pakistan | 31 | 2024 | 76 | 1.720 |
Why?
| | Body Mass Index | 23 | 2023 | 2375 | 1.710 |
Why?
| | Gastric Bypass | 6 | 2019 | 119 | 1.680 |
Why?
| | Dietary Proteins | 11 | 2025 | 135 | 1.670 |
Why?
| | Trace Elements | 13 | 2022 | 51 | 1.640 |
Why?
| | Delivery, Obstetric | 19 | 2025 | 144 | 1.630 |
Why?
| | Pregnancy Complications | 17 | 2025 | 524 | 1.620 |
Why?
| | Mothers | 13 | 2024 | 752 | 1.560 |
Why?
| | Energy Intake | 12 | 2025 | 484 | 1.540 |
Why?
| | Maternal Mortality | 18 | 2025 | 45 | 1.490 |
Why?
| | Gastrointestinal Microbiome | 10 | 2025 | 697 | 1.460 |
Why?
| | Birth Weight | 22 | 2024 | 514 | 1.460 |
Why?
| | Pregnancy Complications, Infectious | 9 | 2025 | 390 | 1.410 |
Why?
| | Infant, Small for Gestational Age | 6 | 2021 | 91 | 1.350 |
Why?
| | Malnutrition | 5 | 2025 | 82 | 1.340 |
Why?
| | Growth | 7 | 2020 | 60 | 1.310 |
Why?
| | Maternal Health | 6 | 2023 | 49 | 1.270 |
Why?
| | Adult | 114 | 2025 | 37630 | 1.250 |
Why?
| | Zea mays | 12 | 2017 | 41 | 1.240 |
Why?
| | Nutrition Assessment | 5 | 2025 | 91 | 1.230 |
Why?
| | Anthropometry | 13 | 2024 | 213 | 1.230 |
Why?
| | Infant, Premature | 9 | 2023 | 566 | 1.220 |
Why?
| | Anemia | 9 | 2025 | 170 | 1.200 |
Why?
| | Child | 71 | 2024 | 21822 | 1.180 |
Why?
| | Zinc Isotopes | 22 | 2011 | 22 | 1.160 |
Why?
| | Child, Preschool | 52 | 2025 | 11000 | 1.160 |
Why?
| | Gastrectomy | 3 | 2021 | 123 | 1.160 |
Why?
| | Gestational Age | 15 | 2023 | 902 | 1.150 |
Why?
| | Child Nutritional Physiological Phenomena | 9 | 2019 | 107 | 1.150 |
Why?
| | Rural Population | 18 | 2022 | 560 | 1.110 |
Why?
| | Feeding Behavior | 12 | 2023 | 648 | 1.090 |
Why?
| | Infant, Low Birth Weight | 13 | 2024 | 140 | 1.080 |
Why?
| | Pre-Eclampsia | 5 | 2023 | 189 | 1.080 |
Why?
| | Prospective Studies | 50 | 2025 | 7572 | 1.050 |
Why?
| | Biological Availability | 22 | 2022 | 148 | 1.040 |
Why?
| | Registries | 27 | 2023 | 2015 | 1.010 |
Why?
| | Body Composition | 10 | 2025 | 679 | 1.010 |
Why?
| | Nutritional Sciences | 5 | 2019 | 43 | 1.000 |
Why?
| | India | 19 | 2025 | 193 | 1.000 |
Why?
| | Biomarkers | 22 | 2025 | 4143 | 1.000 |
Why?
| | Zambia | 18 | 2024 | 57 | 0.990 |
Why?
| | Food | 3 | 2020 | 160 | 0.980 |
Why?
| | Male | 119 | 2025 | 67309 | 0.970 |
Why?
| | Azithromycin | 6 | 2025 | 95 | 0.950 |
Why?
| | Vitamins | 4 | 2025 | 185 | 0.950 |
Why?
| | Weaning | 6 | 2024 | 47 | 0.910 |
Why?
| | Young Adult | 54 | 2025 | 13129 | 0.900 |
Why?
| | Birth Intervals | 2 | 2021 | 22 | 0.890 |
Why?
| | Perinatal Mortality | 10 | 2022 | 16 | 0.890 |
Why?
| | Double-Blind Method | 21 | 2025 | 1981 | 0.880 |
Why?
| | Vaginal Birth after Cesarean | 2 | 2021 | 25 | 0.880 |
Why?
| | Democratic Republic of the Congo | 14 | 2025 | 30 | 0.870 |
Why?
| | Powders | 10 | 2025 | 41 | 0.860 |
Why?
| | Postpartum Period | 6 | 2024 | 337 | 0.850 |
Why?
| | Congenital Abnormalities | 3 | 2020 | 88 | 0.840 |
Why?
| | Premenopause | 3 | 2021 | 131 | 0.820 |
Why?
| | Anastomosis, Roux-en-Y | 2 | 2021 | 28 | 0.800 |
Why?
| | Maternal Health Services | 6 | 2019 | 97 | 0.800 |
Why?
| | Education, Medical | 4 | 2019 | 260 | 0.800 |
Why?
| | Hemoglobins | 8 | 2025 | 353 | 0.790 |
Why?
| | Amino Acids, Branched-Chain | 2 | 2021 | 36 | 0.770 |
Why?
| | Women's Health | 13 | 2023 | 369 | 0.760 |
Why?
| | Obstetric Labor Complications | 6 | 2020 | 34 | 0.760 |
Why?
| | Overweight | 7 | 2023 | 557 | 0.750 |
Why?
| | Vegetables | 2 | 2022 | 156 | 0.750 |
Why?
| | Inflammation | 6 | 2022 | 2834 | 0.750 |
Why?
| | Edible Grain | 7 | 2014 | 49 | 0.730 |
Why?
| | Cesarean Section, Repeat | 1 | 2021 | 11 | 0.730 |
Why?
| | Weight Reduction Programs | 2 | 2013 | 116 | 0.720 |
Why?
| | Body Height | 6 | 2022 | 199 | 0.710 |
Why?
| | Nutritive Value | 3 | 2024 | 37 | 0.700 |
Why?
| | Models, Biological | 9 | 2016 | 1773 | 0.680 |
Why?
| | Deficiency Diseases | 6 | 2019 | 10 | 0.670 |
Why?
| | Weight Gain | 8 | 2023 | 519 | 0.670 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2020 | 13 | 0.650 |
Why?
| | Adolescent | 48 | 2025 | 21382 | 0.650 |
Why?
| | Ultrasonography, Prenatal | 6 | 2020 | 284 | 0.650 |
Why?
| | Recommended Dietary Allowances | 3 | 2018 | 18 | 0.650 |
Why?
| | Milk Banks | 1 | 2019 | 1 | 0.650 |
Why?
| | Health Education | 4 | 2018 | 338 | 0.630 |
Why?
| | Malabsorption Syndromes | 1 | 2019 | 16 | 0.630 |
Why?
| | Dietary Fats | 2 | 2020 | 304 | 0.620 |
Why?
| | Pregnancy Complications, Parasitic | 1 | 2019 | 9 | 0.620 |
Why?
| | Iron Metabolism Disorders | 2 | 2015 | 5 | 0.610 |
Why?
| | Maternal Death | 4 | 2020 | 11 | 0.610 |
Why?
| | Developed Countries | 2 | 2015 | 39 | 0.600 |
Why?
| | Bangladesh | 8 | 2025 | 56 | 0.600 |
Why?
| | Organic Chemicals | 1 | 2020 | 124 | 0.590 |
Why?
| | Quality Assurance, Health Care | 1 | 2020 | 322 | 0.590 |
Why?
| | Malaria | 1 | 2019 | 63 | 0.590 |
Why?
| | Avitaminosis | 1 | 2018 | 7 | 0.580 |
Why?
| | Metabolomics | 2 | 2021 | 678 | 0.580 |
Why?
| | Longitudinal Studies | 19 | 2023 | 2829 | 0.580 |
Why?
| | Nutrition Therapy | 2 | 2019 | 36 | 0.580 |
Why?
| | Parity | 8 | 2023 | 125 | 0.570 |
Why?
| | Enteritis | 1 | 2019 | 103 | 0.570 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2017 | 549 | 0.560 |
Why?
| | Sepsis | 4 | 2025 | 614 | 0.560 |
Why?
| | Kenya | 11 | 2024 | 116 | 0.560 |
Why?
| | Prevalence | 14 | 2025 | 2711 | 0.560 |
Why?
| | Body Size | 6 | 2019 | 108 | 0.550 |
Why?
| | Anti-Bacterial Agents | 5 | 2025 | 1798 | 0.540 |
Why?
| | Diarrhea | 5 | 2022 | 184 | 0.540 |
Why?
| | Weight Loss | 2 | 2013 | 776 | 0.540 |
Why?
| | Body Weight | 13 | 2019 | 985 | 0.530 |
Why?
| | Insulin | 7 | 2021 | 2406 | 0.530 |
Why?
| | Sodium Chloride, Dietary | 3 | 2025 | 36 | 0.520 |
Why?
| | Metabolome | 1 | 2020 | 350 | 0.510 |
Why?
| | Leptin | 5 | 2018 | 236 | 0.500 |
Why?
| | Vitamin E | 1 | 2016 | 124 | 0.500 |
Why?
| | Global Health | 10 | 2025 | 385 | 0.490 |
Why?
| | Child Nutrition Sciences | 1 | 2015 | 8 | 0.490 |
Why?
| | Gastrointestinal Absorption | 1 | 2014 | 5 | 0.460 |
Why?
| | Brain | 2 | 2017 | 2664 | 0.460 |
Why?
| | Starch | 1 | 2015 | 22 | 0.460 |
Why?
| | Cross-Sectional Studies | 25 | 2023 | 5423 | 0.460 |
Why?
| | Pregnancy Trimester, First | 7 | 2023 | 140 | 0.460 |
Why?
| | Nutrition Policy | 6 | 2017 | 61 | 0.460 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 5 | 2024 | 59 | 0.450 |
Why?
| | Calcium | 5 | 2022 | 1197 | 0.440 |
Why?
| | Health Promotion | 4 | 2023 | 734 | 0.440 |
Why?
| | Cohort Studies | 14 | 2021 | 5701 | 0.440 |
Why?
| | Infant, Premature, Diseases | 1 | 2015 | 100 | 0.440 |
Why?
| | Aging | 6 | 2018 | 1861 | 0.440 |
Why?
| | Risk Factors | 26 | 2025 | 10326 | 0.440 |
Why?
| | Age Factors | 9 | 2015 | 3284 | 0.430 |
Why?
| | Adiposity | 3 | 2018 | 518 | 0.430 |
Why?
| | Pediatrics | 6 | 2018 | 1096 | 0.420 |
Why?
| | Calcium, Dietary | 5 | 2022 | 57 | 0.420 |
Why?
| | Educational Status | 11 | 2022 | 470 | 0.420 |
Why?
| | Socioeconomic Factors | 13 | 2024 | 1282 | 0.420 |
Why?
| | Diet, Mediterranean | 2 | 2024 | 30 | 0.410 |
Why?
| | Income | 9 | 2023 | 202 | 0.410 |
Why?
| | Regression Analysis | 10 | 2016 | 1022 | 0.410 |
Why?
| | Dysprosium | 2 | 2010 | 2 | 0.400 |
Why?
| | Aspirin | 6 | 2024 | 387 | 0.400 |
Why?
| | Randomized Controlled Trials as Topic | 9 | 2025 | 1462 | 0.390 |
Why?
| | Antioxidants | 1 | 2016 | 584 | 0.390 |
Why?
| | Flour | 4 | 2015 | 6 | 0.390 |
Why?
| | Hypertension, Pregnancy-Induced | 2 | 2023 | 68 | 0.390 |
Why?
| | Neurodevelopmental Disorders | 3 | 2023 | 176 | 0.390 |
Why?
| | Occupational Health Services | 1 | 2012 | 32 | 0.390 |
Why?
| | Pregnancy Trimester, Third | 3 | 2017 | 114 | 0.380 |
Why?
| | Triticum | 2 | 2009 | 17 | 0.380 |
Why?
| | Metagenome | 1 | 2013 | 147 | 0.380 |
Why?
| | Heme | 1 | 2012 | 78 | 0.380 |
Why?
| | Intestinal Mucosa | 7 | 2018 | 621 | 0.370 |
Why?
| | Dietary Carbohydrates | 2 | 2010 | 155 | 0.370 |
Why?
| | Protein Hydrolysates | 2 | 2002 | 6 | 0.370 |
Why?
| | Glucocorticoids | 4 | 2016 | 593 | 0.370 |
Why?
| | Caseins | 2 | 2002 | 20 | 0.360 |
Why?
| | Insulin-Like Growth Factor I | 3 | 2021 | 316 | 0.360 |
Why?
| | Maternal Age | 12 | 2020 | 129 | 0.360 |
Why?
| | Social Class | 3 | 2022 | 281 | 0.350 |
Why?
| | Public Health | 4 | 2025 | 579 | 0.340 |
Why?
| | Labor, Obstetric | 2 | 2021 | 61 | 0.340 |
Why?
| | Gastrointestinal Tract | 1 | 2013 | 195 | 0.340 |
Why?
| | Zika Virus Infection | 2 | 2025 | 165 | 0.340 |
Why?
| | Maternal-Child Health Services | 3 | 2019 | 12 | 0.330 |
Why?
| | Workplace | 1 | 2012 | 258 | 0.330 |
Why?
| | Failure to Thrive | 3 | 2009 | 29 | 0.330 |
Why?
| | Wasting Syndrome | 1 | 2010 | 13 | 0.330 |
Why?
| | Plant Preparations | 1 | 2010 | 36 | 0.330 |
Why?
| | Biological Transport | 3 | 2021 | 416 | 0.320 |
Why?
| | Cardiovascular Diseases | 4 | 2024 | 2104 | 0.320 |
Why?
| | Nutritional Physiological Phenomena | 4 | 2022 | 54 | 0.320 |
Why?
| | Time Factors | 9 | 2021 | 6806 | 0.320 |
Why?
| | Nutrition Surveys | 1 | 2011 | 266 | 0.320 |
Why?
| | Absorption | 11 | 2013 | 63 | 0.310 |
Why?
| | Quality Indicators, Health Care | 1 | 2012 | 307 | 0.310 |
Why?
| | Staining and Labeling | 1 | 2009 | 148 | 0.300 |
Why?
| | Folic Acid | 4 | 2025 | 185 | 0.300 |
Why?
| | Fetus | 4 | 2021 | 806 | 0.300 |
Why?
| | Medically Underserved Area | 3 | 2018 | 85 | 0.300 |
Why?
| | Iodine | 3 | 2025 | 27 | 0.290 |
Why?
| | Patient Safety | 1 | 2012 | 308 | 0.290 |
Why?
| | Lipids | 2 | 2024 | 665 | 0.290 |
Why?
| | Salmon | 2 | 2025 | 22 | 0.290 |
Why?
| | Diet Records | 5 | 2014 | 83 | 0.290 |
Why?
| | Seafood | 2 | 2025 | 27 | 0.290 |
Why?
| | Cross-Over Studies | 6 | 2020 | 562 | 0.290 |
Why?
| | Practice Guidelines as Topic | 4 | 2016 | 1571 | 0.270 |
Why?
| | Logistic Models | 4 | 2021 | 2067 | 0.270 |
Why?
| | Health Knowledge, Attitudes, Practice | 6 | 2023 | 1320 | 0.270 |
Why?
| | Antibiotic Prophylaxis | 2 | 2025 | 115 | 0.270 |
Why?
| | Pediatric Obesity | 3 | 2023 | 590 | 0.260 |
Why?
| | Cytokines | 3 | 2021 | 2083 | 0.260 |
Why?
| | Folic Acid Deficiency | 2 | 2025 | 49 | 0.260 |
Why?
| | Urinalysis | 5 | 2020 | 77 | 0.260 |
Why?
| | Administration, Oral | 7 | 2023 | 813 | 0.260 |
Why?
| | Diabetes, Gestational | 2 | 2021 | 316 | 0.260 |
Why?
| | Minerals | 2 | 2025 | 42 | 0.260 |
Why?
| | Adiponectin | 2 | 2018 | 244 | 0.260 |
Why?
| | Referral and Consultation | 3 | 2019 | 780 | 0.250 |
Why?
| | Follow-Up Studies | 7 | 2024 | 5106 | 0.250 |
Why?
| | Communicable Diseases | 2 | 2023 | 159 | 0.250 |
Why?
| | Health Personnel | 3 | 2023 | 701 | 0.250 |
Why?
| | Blueberry Plants | 1 | 2025 | 7 | 0.240 |
Why?
| | Cause of Death | 2 | 2018 | 430 | 0.240 |
Why?
| | Fish Products | 1 | 2025 | 7 | 0.240 |
Why?
| | Risk Assessment | 7 | 2018 | 3432 | 0.230 |
Why?
| | Bone and Bones | 2 | 2019 | 316 | 0.230 |
Why?
| | Colorado | 7 | 2017 | 4518 | 0.230 |
Why?
| | Environment | 2 | 2017 | 357 | 0.230 |
Why?
| | Internship and Residency | 2 | 2019 | 1132 | 0.230 |
Why?
| | Perinatal Care | 2 | 2018 | 56 | 0.230 |
Why?
| | Schools, Medical | 1 | 2006 | 145 | 0.230 |
Why?
| | Microcephaly | 1 | 2025 | 97 | 0.220 |
Why?
| | Feasibility Studies | 4 | 2023 | 951 | 0.220 |
Why?
| | Parents | 1 | 2013 | 1340 | 0.220 |
Why?
| | Retrospective Studies | 9 | 2023 | 15504 | 0.220 |
Why?
| | Maternal Welfare | 2 | 2014 | 21 | 0.220 |
Why?
| | Agaricus | 1 | 2023 | 3 | 0.220 |
Why?
| | Asia | 6 | 2020 | 70 | 0.210 |
Why?
| | China | 5 | 2014 | 216 | 0.210 |
Why?
| | Erythrocytes | 5 | 2022 | 699 | 0.210 |
Why?
| | Reference Values | 4 | 2022 | 816 | 0.210 |
Why?
| | Ferritins | 2 | 2016 | 64 | 0.210 |
Why?
| | Milk | 3 | 2018 | 124 | 0.200 |
Why?
| | Soybean Proteins | 1 | 2002 | 14 | 0.200 |
Why?
| | Vitamin K | 1 | 2023 | 45 | 0.200 |
Why?
| | Vitamin A | 1 | 2023 | 58 | 0.200 |
Why?
| | Dietary Fats, Unsaturated | 1 | 2002 | 23 | 0.200 |
Why?
| | Food Assistance | 1 | 2023 | 30 | 0.200 |
Why?
| | Plant Oils | 1 | 2002 | 31 | 0.200 |
Why?
| | Labor Presentation | 2 | 2019 | 2 | 0.200 |
Why?
| | Faculty, Medical | 1 | 2006 | 283 | 0.200 |
Why?
| | Pandemics | 4 | 2024 | 1613 | 0.200 |
Why?
| | Parenteral Nutrition | 1 | 2024 | 107 | 0.200 |
Why?
| | Infant Care | 2 | 2015 | 45 | 0.200 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2023 | 106 | 0.200 |
Why?
| | Health Facilities | 2 | 2020 | 83 | 0.200 |
Why?
| | Temperature | 2 | 2023 | 675 | 0.190 |
Why?
| | Oryza | 1 | 2022 | 33 | 0.190 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2020 | 605 | 0.190 |
Why?
| | Dose-Response Relationship, Drug | 6 | 2019 | 2052 | 0.190 |
Why?
| | Puerperal Infection | 3 | 2024 | 5 | 0.190 |
Why?
| | Hypersensitivity | 1 | 2025 | 257 | 0.190 |
Why?
| | Midwifery | 3 | 2014 | 52 | 0.190 |
Why?
| | United States | 14 | 2023 | 14691 | 0.190 |
Why?
| | Postnatal Care | 2 | 2020 | 70 | 0.190 |
Why?
| | Africa | 5 | 2023 | 108 | 0.190 |
Why?
| | Fatty Acids | 3 | 2022 | 442 | 0.190 |
Why?
| | Adolescent Health | 2 | 2019 | 39 | 0.190 |
Why?
| | Zinc Oxide | 3 | 2012 | 9 | 0.180 |
Why?
| | Biomedical Research | 3 | 2017 | 688 | 0.180 |
Why?
| | Intestinal Diseases | 1 | 2022 | 42 | 0.180 |
Why?
| | Tobacco, Smokeless | 1 | 2021 | 13 | 0.180 |
Why?
| | Students | 1 | 2007 | 622 | 0.180 |
Why?
| | Rural Health | 5 | 2016 | 79 | 0.180 |
Why?
| | Enteral Nutrition | 1 | 2024 | 201 | 0.180 |
Why?
| | Adrenal Cortex Hormones | 2 | 2016 | 556 | 0.180 |
Why?
| | Patient Dropouts | 2 | 2012 | 67 | 0.180 |
Why?
| | Bone Density | 3 | 2006 | 487 | 0.180 |
Why?
| | Tablets | 4 | 2022 | 40 | 0.180 |
Why?
| | Amino Acids, Essential | 1 | 2021 | 13 | 0.180 |
Why?
| | Isoleucine | 1 | 2021 | 14 | 0.180 |
Why?
| | Cystic Fibrosis | 3 | 2000 | 1108 | 0.180 |
Why?
| | Selenoproteins | 1 | 2020 | 7 | 0.170 |
Why?
| | Birth Rate | 1 | 2020 | 30 | 0.170 |
Why?
| | Phenylalanine | 1 | 2021 | 68 | 0.170 |
Why?
| | Vitamin B 12 | 3 | 2025 | 128 | 0.170 |
Why?
| | Treatment Outcome | 5 | 2018 | 10744 | 0.170 |
Why?
| | Valine | 1 | 2021 | 82 | 0.170 |
Why?
| | Animals | 16 | 2025 | 36823 | 0.170 |
Why?
| | Surveys and Questionnaires | 7 | 2020 | 5742 | 0.170 |
Why?
| | Digestive System Physiological Phenomena | 1 | 2000 | 4 | 0.170 |
Why?
| | Hyperinsulinism | 1 | 2021 | 121 | 0.170 |
Why?
| | Carnitine | 1 | 2021 | 84 | 0.170 |
Why?
| | Leucine | 1 | 2021 | 111 | 0.170 |
Why?
| | Cleft Lip | 1 | 2020 | 51 | 0.170 |
Why?
| | Parturition | 1 | 2021 | 71 | 0.170 |
Why?
| | Oligohydramnios | 1 | 2020 | 12 | 0.160 |
Why?
| | Quality of Health Care | 3 | 2020 | 634 | 0.160 |
Why?
| | Cleft Palate | 1 | 2020 | 67 | 0.160 |
Why?
| | Biotransformation | 1 | 2020 | 65 | 0.160 |
Why?
| | Spouses | 1 | 2021 | 105 | 0.160 |
Why?
| | Pasteurization | 1 | 2019 | 1 | 0.160 |
Why?
| | Endotoxemia | 1 | 2020 | 86 | 0.160 |
Why?
| | Digestion | 2 | 2017 | 10 | 0.160 |
Why?
| | Linear Models | 4 | 2016 | 846 | 0.160 |
Why?
| | International Classification of Diseases | 1 | 2020 | 132 | 0.160 |
Why?
| | Thinness | 2 | 2018 | 91 | 0.160 |
Why?
| | Latin America | 5 | 2018 | 93 | 0.160 |
Why?
| | Diet, Fat-Restricted | 1 | 2000 | 79 | 0.160 |
Why?
| | Lactulose | 1 | 2019 | 1 | 0.160 |
Why?
| | Liver | 6 | 2020 | 1940 | 0.160 |
Why?
| | Polyhydramnios | 1 | 2019 | 17 | 0.160 |
Why?
| | Health Resources | 1 | 2020 | 119 | 0.160 |
Why?
| | Calorimetry | 1 | 2019 | 70 | 0.160 |
Why?
| | Anemia, Sickle Cell | 1 | 2023 | 269 | 0.160 |
Why?
| | Mannitol | 1 | 2019 | 38 | 0.160 |
Why?
| | Pilot Projects | 3 | 2023 | 1692 | 0.160 |
Why?
| | Intestines | 3 | 2019 | 357 | 0.160 |
Why?
| | Cholesterol, HDL | 2 | 2023 | 203 | 0.160 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2020 | 180 | 0.160 |
Why?
| | Hepcidins | 1 | 2019 | 22 | 0.150 |
Why?
| | Endemic Diseases | 1 | 2019 | 32 | 0.150 |
Why?
| | Middle Aged | 10 | 2025 | 33228 | 0.150 |
Why?
| | Hypersensitivity, Immediate | 1 | 2019 | 44 | 0.150 |
Why?
| | Malawi | 4 | 2015 | 53 | 0.150 |
Why?
| | Beverages | 4 | 2019 | 69 | 0.150 |
Why?
| | Species Specificity | 1 | 2020 | 584 | 0.150 |
Why?
| | Ghrelin | 1 | 2018 | 36 | 0.150 |
Why?
| | Exercise | 7 | 2023 | 2043 | 0.150 |
Why?
| | Interdisciplinary Communication | 1 | 2019 | 191 | 0.150 |
Why?
| | Blood Urea Nitrogen | 1 | 2018 | 54 | 0.150 |
Why?
| | Glucose | 3 | 2023 | 1019 | 0.150 |
Why?
| | Insulin-Like Growth Factor Binding Protein 3 | 1 | 2018 | 39 | 0.150 |
Why?
| | Oxidative Stress | 2 | 2017 | 1314 | 0.140 |
Why?
| | Adolescent Development | 1 | 2019 | 86 | 0.140 |
Why?
| | Meat Products | 2 | 2012 | 25 | 0.140 |
Why?
| | Erythrocyte Indices | 2 | 2021 | 30 | 0.140 |
Why?
| | Postoperative Complications | 2 | 2009 | 2639 | 0.140 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2021 | 412 | 0.140 |
Why?
| | Proteobacteria | 1 | 2017 | 15 | 0.140 |
Why?
| | Clostridium | 1 | 2017 | 17 | 0.140 |
Why?
| | Bifidobacterium | 1 | 2017 | 20 | 0.140 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2020 | 597 | 0.140 |
Why?
| | Food Supply | 1 | 2018 | 80 | 0.140 |
Why?
| | Indians, Central American | 1 | 2017 | 6 | 0.140 |
Why?
| | Cluster Analysis | 5 | 2019 | 497 | 0.140 |
Why?
| | Infusions, Intravenous | 3 | 2006 | 412 | 0.130 |
Why?
| | Head | 2 | 2010 | 105 | 0.130 |
Why?
| | Communication | 1 | 2023 | 875 | 0.130 |
Why?
| | Isotopes | 1 | 2017 | 33 | 0.130 |
Why?
| | Copper | 3 | 2004 | 104 | 0.130 |
Why?
| | Vaccines | 1 | 2022 | 405 | 0.130 |
Why?
| | Guidelines as Topic | 1 | 2019 | 275 | 0.130 |
Why?
| | Appetite | 2 | 2010 | 69 | 0.130 |
Why?
| | Social Determinants of Health | 1 | 2020 | 255 | 0.130 |
Why?
| | Food Analysis | 2 | 2015 | 26 | 0.130 |
Why?
| | Professional-Family Relations | 1 | 2018 | 141 | 0.130 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2016 | 47 | 0.130 |
Why?
| | Biomedical Technology | 1 | 2017 | 43 | 0.130 |
Why?
| | Gene Expression | 1 | 2021 | 1500 | 0.130 |
Why?
| | Africa South of the Sahara | 4 | 2018 | 48 | 0.130 |
Why?
| | Dietary Sucrose | 1 | 2016 | 49 | 0.130 |
Why?
| | Interleukin-8 | 1 | 2017 | 268 | 0.130 |
Why?
| | Intensive Care, Neonatal | 1 | 2016 | 40 | 0.130 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 98 | 0.130 |
Why?
| | Population Surveillance | 4 | 2020 | 474 | 0.120 |
Why?
| | Down-Regulation | 1 | 2018 | 656 | 0.120 |
Why?
| | Blood Pressure | 2 | 2020 | 1774 | 0.120 |
Why?
| | Spectrophotometry, Atomic | 8 | 2013 | 13 | 0.120 |
Why?
| | Ethiopia | 4 | 2009 | 41 | 0.120 |
Why?
| | Reproducibility of Results | 3 | 2020 | 3264 | 0.120 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2016 | 139 | 0.120 |
Why?
| | Insulin Resistance | 2 | 2021 | 1203 | 0.120 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 279 | 0.120 |
Why?
| | Overnutrition | 1 | 2015 | 30 | 0.120 |
Why?
| | Diabetes Mellitus | 4 | 2016 | 1032 | 0.110 |
Why?
| | American Heart Association | 1 | 2016 | 306 | 0.110 |
Why?
| | Data Accuracy | 1 | 2015 | 65 | 0.110 |
Why?
| | Haemophilus influenzae type b | 1 | 2014 | 12 | 0.110 |
Why?
| | Bacterial Capsules | 1 | 2014 | 30 | 0.110 |
Why?
| | Haemophilus Vaccines | 1 | 2014 | 30 | 0.110 |
Why?
| | Risk Reduction Behavior | 1 | 2016 | 218 | 0.110 |
Why?
| | Stroke | 1 | 2023 | 1118 | 0.110 |
Why?
| | Antibody Affinity | 1 | 2014 | 60 | 0.110 |
Why?
| | Drug Utilization | 3 | 2024 | 169 | 0.110 |
Why?
| | World Health Organization | 3 | 2012 | 123 | 0.110 |
Why?
| | Multivariate Analysis | 5 | 2020 | 1507 | 0.110 |
Why?
| | Pregnancy in Adolescence | 1 | 2015 | 81 | 0.110 |
Why?
| | Chile | 2 | 2012 | 24 | 0.110 |
Why?
| | Contraception Behavior | 1 | 2015 | 102 | 0.110 |
Why?
| | Cost-Benefit Analysis | 3 | 2025 | 587 | 0.110 |
Why?
| | Placenta | 1 | 2021 | 749 | 0.110 |
Why?
| | Algorithms | 3 | 2017 | 1689 | 0.110 |
Why?
| | Sequence Analysis, DNA | 1 | 2017 | 809 | 0.110 |
Why?
| | Pneumonia | 2 | 1999 | 635 | 0.110 |
Why?
| | Family Planning Services | 1 | 2015 | 92 | 0.110 |
Why?
| | Life Style | 2 | 2015 | 487 | 0.110 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 350 | 0.110 |
Why?
| | Up-Regulation | 1 | 2017 | 843 | 0.110 |
Why?
| | Food Preferences | 1 | 2015 | 119 | 0.110 |
Why?
| | Bacterial Infections | 1 | 2016 | 250 | 0.110 |
Why?
| | Health Services Accessibility | 2 | 2019 | 978 | 0.110 |
Why?
| | Qualitative Research | 1 | 2021 | 1366 | 0.110 |
Why?
| | Antibodies, Bacterial | 1 | 2014 | 146 | 0.110 |
Why?
| | Pennisetum | 1 | 2013 | 2 | 0.110 |
Why?
| | Central America | 2 | 2025 | 24 | 0.100 |
Why?
| | Acrodermatitis | 1 | 2013 | 1 | 0.100 |
Why?
| | Hair | 3 | 2011 | 84 | 0.100 |
Why?
| | Alkaline Phosphatase | 3 | 2011 | 148 | 0.100 |
Why?
| | Needs Assessment | 2 | 2015 | 372 | 0.100 |
Why?
| | Health Services Needs and Demand | 1 | 2015 | 271 | 0.100 |
Why?
| | Population Groups | 1 | 2013 | 62 | 0.100 |
Why?
| | Pregnancy, Multiple | 1 | 2013 | 17 | 0.100 |
Why?
| | Neonatology | 1 | 2013 | 29 | 0.100 |
Why?
| | Escherichia coli | 1 | 2017 | 806 | 0.100 |
Why?
| | Liver Diseases | 3 | 2013 | 311 | 0.100 |
Why?
| | Puerperal Disorders | 3 | 2020 | 31 | 0.100 |
Why?
| | Indicator Dilution Techniques | 4 | 2006 | 11 | 0.100 |
Why?
| | Puerto Rico | 2 | 2025 | 53 | 0.100 |
Why?
| | Iron Radioisotopes | 1 | 2012 | 2 | 0.100 |
Why?
| | Prolactin | 2 | 2007 | 96 | 0.100 |
Why?
| | Fetal Growth Retardation | 3 | 2025 | 564 | 0.100 |
Why?
| | Endocrine System | 1 | 2012 | 20 | 0.100 |
Why?
| | Poverty Areas | 1 | 2012 | 39 | 0.100 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2012 | 31 | 0.100 |
Why?
| | Urban Health | 1 | 2012 | 92 | 0.100 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2012 | 62 | 0.100 |
Why?
| | Hospitals, University | 1 | 2012 | 182 | 0.090 |
Why?
| | Clinical Competence | 1 | 2019 | 1094 | 0.090 |
Why?
| | Triglycerides | 1 | 2014 | 524 | 0.090 |
Why?
| | Mammary Glands, Human | 1 | 2012 | 64 | 0.090 |
Why?
| | Intestine, Small | 2 | 2011 | 156 | 0.090 |
Why?
| | Obstetrics | 1 | 2013 | 162 | 0.090 |
Why?
| | Analysis of Variance | 3 | 2002 | 1316 | 0.090 |
Why?
| | Cerebrovascular Disorders | 1 | 2012 | 96 | 0.090 |
Why?
| | Morphogenesis | 1 | 2012 | 166 | 0.090 |
Why?
| | Erythrocyte Membrane | 1 | 2011 | 55 | 0.090 |
Why?
| | Zika Virus | 2 | 2025 | 128 | 0.090 |
Why?
| | Curriculum | 3 | 2019 | 976 | 0.090 |
Why?
| | Chickens | 1 | 2011 | 191 | 0.090 |
Why?
| | International Agencies | 1 | 2011 | 35 | 0.090 |
Why?
| | Spectrometry, Mass, Fast Atom Bombardment | 4 | 1998 | 8 | 0.090 |
Why?
| | Incidence | 4 | 2019 | 2792 | 0.090 |
Why?
| | Digestive System | 2 | 2001 | 27 | 0.090 |
Why?
| | Single-Blind Method | 1 | 2011 | 282 | 0.090 |
Why?
| | Growth Charts | 1 | 2010 | 14 | 0.090 |
Why?
| | Interviews as Topic | 1 | 2014 | 772 | 0.080 |
Why?
| | Inositol Phosphates | 1 | 2010 | 22 | 0.080 |
Why?
| | Dexamethasone | 1 | 2012 | 368 | 0.080 |
Why?
| | Language | 1 | 2013 | 292 | 0.080 |
Why?
| | Interleukin-6 | 1 | 2014 | 778 | 0.080 |
Why?
| | Food, Formulated | 1 | 1989 | 14 | 0.080 |
Why?
| | Argentina | 3 | 2014 | 26 | 0.080 |
Why?
| | Child Welfare | 1 | 2012 | 212 | 0.080 |
Why?
| | Physicians | 2 | 2019 | 907 | 0.080 |
Why?
| | Family Nursing | 1 | 2009 | 14 | 0.080 |
Why?
| | Public Assistance | 1 | 2009 | 20 | 0.080 |
Why?
| | Manganese | 1 | 1989 | 62 | 0.080 |
Why?
| | Program Evaluation | 1 | 2014 | 889 | 0.080 |
Why?
| | Blood Glucose | 2 | 2021 | 2181 | 0.080 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1242 | 0.080 |
Why?
| | Mexico | 1 | 2009 | 225 | 0.080 |
Why?
| | Patient Acceptance of Health Care | 1 | 2015 | 805 | 0.070 |
Why?
| | Cattle | 2 | 2024 | 981 | 0.070 |
Why?
| | Patient Compliance | 1 | 2012 | 577 | 0.070 |
Why?
| | Hospitals, Pediatric | 1 | 2012 | 506 | 0.070 |
Why?
| | Celiac Disease | 1 | 2011 | 294 | 0.070 |
Why?
| | Congo | 2 | 2020 | 4 | 0.070 |
Why?
| | Safety | 1 | 2010 | 338 | 0.070 |
Why?
| | Health Planning Guidelines | 1 | 2007 | 25 | 0.070 |
Why?
| | Ascorbic Acid | 1 | 2009 | 176 | 0.070 |
Why?
| | Urban Population | 3 | 2018 | 476 | 0.070 |
Why?
| | Food Handling | 2 | 2025 | 61 | 0.070 |
Why?
| | Nutrition Disorders | 1 | 2007 | 23 | 0.070 |
Why?
| | Disease Management | 1 | 2012 | 624 | 0.070 |
Why?
| | Fatty Acids, Volatile | 2 | 2018 | 56 | 0.070 |
Why?
| | Cognition | 2 | 2009 | 1146 | 0.070 |
Why?
| | Child Behavior | 1 | 2009 | 246 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2021 | 2518 | 0.070 |
Why?
| | Combined Modality Therapy | 1 | 2010 | 1231 | 0.070 |
Why?
| | Sensitivity and Specificity | 2 | 2009 | 1935 | 0.060 |
Why?
| | Mutation | 2 | 2013 | 3946 | 0.060 |
Why?
| | Sex Factors | 2 | 2010 | 2060 | 0.060 |
Why?
| | Injections, Intravenous | 3 | 2004 | 206 | 0.060 |
Why?
| | Aged | 3 | 2023 | 23794 | 0.060 |
Why?
| | Carrier Proteins | 2 | 2002 | 769 | 0.060 |
Why?
| | Research Design | 2 | 2019 | 1127 | 0.060 |
Why?
| | Caregivers | 1 | 2014 | 870 | 0.060 |
Why?
| | Proteins | 1 | 2012 | 1008 | 0.060 |
Why?
| | South America | 1 | 2025 | 59 | 0.060 |
Why?
| | Sex Characteristics | 1 | 2011 | 759 | 0.060 |
Why?
| | Postprandial Period | 2 | 1997 | 107 | 0.060 |
Why?
| | Xanthophylls | 1 | 2025 | 18 | 0.060 |
Why?
| | Isomerism | 1 | 2025 | 56 | 0.060 |
Why?
| | Problem-Based Learning | 1 | 2006 | 91 | 0.060 |
Why?
| | Malaria, Falciparum | 1 | 2005 | 27 | 0.060 |
Why?
| | Energy Metabolism | 2 | 2015 | 919 | 0.060 |
Why?
| | Education, Medical, Continuing | 1 | 2006 | 127 | 0.060 |
Why?
| | Vitamin B 12 Deficiency | 1 | 2025 | 81 | 0.060 |
Why?
| | Fruit | 1 | 2025 | 139 | 0.060 |
Why?
| | Obstetric Labor, Premature | 2 | 2016 | 36 | 0.060 |
Why?
| | Gastroplasty | 1 | 2004 | 30 | 0.060 |
Why?
| | Health Behavior | 2 | 2023 | 756 | 0.050 |
Why?
| | Schools | 1 | 2007 | 461 | 0.050 |
Why?
| | Zinc Radioisotopes | 1 | 2003 | 1 | 0.050 |
Why?
| | Hydroxyurea | 1 | 2023 | 35 | 0.050 |
Why?
| | Delivery of Health Care | 2 | 2022 | 934 | 0.050 |
Why?
| | Home Childbirth | 2 | 2013 | 5 | 0.050 |
Why?
| | Neonatal Sepsis | 1 | 2023 | 4 | 0.050 |
Why?
| | Palm Oil | 1 | 2002 | 2 | 0.050 |
Why?
| | Mice, Inbred C57BL | 3 | 2020 | 5735 | 0.050 |
Why?
| | Ethers | 1 | 2022 | 19 | 0.050 |
Why?
| | Sodium Chloride | 1 | 2023 | 142 | 0.050 |
Why?
| | Phosphatidylethanolamines | 1 | 2022 | 77 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 308 | 0.050 |
Why?
| | Docosahexaenoic Acids | 1 | 2022 | 84 | 0.050 |
Why?
| | Genetic Engineering | 1 | 2002 | 91 | 0.050 |
Why?
| | Reference Standards | 1 | 2002 | 186 | 0.050 |
Why?
| | Cholesterol | 1 | 2023 | 410 | 0.050 |
Why?
| | Community Health Services | 1 | 2023 | 227 | 0.050 |
Why?
| | Phospholipids | 1 | 2022 | 222 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2005 | 738 | 0.040 |
Why?
| | Circadian Rhythm | 1 | 1985 | 468 | 0.040 |
Why?
| | Magnesium | 2 | 2001 | 156 | 0.040 |
Why?
| | Animals, Newborn | 2 | 2014 | 844 | 0.040 |
Why?
| | Glutathione Peroxidase | 1 | 2020 | 43 | 0.040 |
Why?
| | Selenium | 1 | 2020 | 39 | 0.040 |
Why?
| | Pregnancy Trimester, Second | 2 | 2019 | 80 | 0.040 |
Why?
| | Metallothionein | 1 | 2000 | 25 | 0.040 |
Why?
| | Orosomucoid | 1 | 2020 | 9 | 0.040 |
Why?
| | Vaccination | 2 | 2022 | 1376 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2021 | 364 | 0.040 |
Why?
| | Licensure | 1 | 2019 | 13 | 0.040 |
Why?
| | Child Abuse | 1 | 2005 | 528 | 0.040 |
Why?
| | Nicaragua | 1 | 2019 | 7 | 0.040 |
Why?
| | HIV Infections | 1 | 2014 | 2828 | 0.040 |
Why?
| | Severity of Illness Index | 2 | 2011 | 2822 | 0.040 |
Why?
| | Zinc Sulfate | 2 | 2012 | 8 | 0.040 |
Why?
| | Colombia | 1 | 2019 | 41 | 0.040 |
Why?
| | Peru | 1 | 2019 | 58 | 0.040 |
Why?
| | Hepatocytes | 1 | 2020 | 220 | 0.040 |
Why?
| | Accreditation | 1 | 2019 | 82 | 0.040 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 1 | 2019 | 104 | 0.040 |
Why?
| | Brazil | 1 | 2019 | 167 | 0.040 |
Why?
| | Family Relations | 1 | 2000 | 89 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2022 | 452 | 0.040 |
Why?
| | Term Birth | 1 | 2018 | 23 | 0.040 |
Why?
| | Asia, Southeastern | 1 | 2018 | 13 | 0.040 |
Why?
| | Germ-Free Life | 1 | 2018 | 34 | 0.040 |
Why?
| | Least-Squares Analysis | 1 | 1998 | 79 | 0.040 |
Why?
| | Amniotic Fluid | 1 | 2019 | 96 | 0.040 |
Why?
| | Rhinitis, Allergic | 1 | 2019 | 38 | 0.040 |
Why?
| | Spleen | 1 | 2020 | 514 | 0.040 |
Why?
| | Gene Expression Regulation | 2 | 2021 | 2605 | 0.040 |
Why?
| | Eczema | 1 | 2019 | 69 | 0.040 |
Why?
| | Organ Specificity | 2 | 2014 | 304 | 0.040 |
Why?
| | Focus Groups | 1 | 2021 | 515 | 0.040 |
Why?
| | Diet, Western | 1 | 2018 | 81 | 0.040 |
Why?
| | Microwaves | 1 | 1998 | 37 | 0.040 |
Why?
| | Immunoglobulin M | 1 | 2019 | 289 | 0.040 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2001 | 288 | 0.030 |
Why?
| | Odds Ratio | 1 | 2020 | 1065 | 0.030 |
Why?
| | Hospitals, Maternity | 1 | 2017 | 4 | 0.030 |
Why?
| | C-Reactive Protein | 1 | 2020 | 408 | 0.030 |
Why?
| | Tuberculosis | 1 | 2000 | 276 | 0.030 |
Why?
| | Pressure | 1 | 1998 | 221 | 0.030 |
Why?
| | Food-Drug Interactions | 1 | 2017 | 9 | 0.030 |
Why?
| | Bile Acids and Salts | 1 | 2018 | 200 | 0.030 |
Why?
| | Fermentation | 1 | 2017 | 26 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2019 | 562 | 0.030 |
Why?
| | Liquid-Liquid Extraction | 1 | 2016 | 14 | 0.030 |
Why?
| | Dysbiosis | 1 | 2018 | 181 | 0.030 |
Why?
| | Chromatography, Gas | 1 | 2016 | 33 | 0.030 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 231 | 0.030 |
Why?
| | Lactobacillales | 1 | 2016 | 5 | 0.030 |
Why?
| | Continuity of Patient Care | 1 | 2019 | 281 | 0.030 |
Why?
| | Gammaproteobacteria | 1 | 2016 | 13 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 1997 | 254 | 0.030 |
Why?
| | Phosphates | 1 | 1997 | 182 | 0.030 |
Why?
| | Pyruvate Kinase | 1 | 2016 | 29 | 0.030 |
Why?
| | Computer Simulation | 1 | 2000 | 973 | 0.030 |
Why?
| | Community Health Centers | 1 | 2016 | 59 | 0.030 |
Why?
| | Food Hypersensitivity | 1 | 2019 | 183 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 106 | 0.030 |
Why?
| | Kidney | 2 | 2020 | 1467 | 0.030 |
Why?
| | RNA, Viral | 1 | 2019 | 654 | 0.030 |
Why?
| | Drug Interactions | 1 | 2017 | 407 | 0.030 |
Why?
| | Reproductive Behavior | 1 | 2015 | 11 | 0.030 |
Why?
| | Dermatitis, Atopic | 1 | 2019 | 329 | 0.030 |
Why?
| | Pancreas | 1 | 1998 | 329 | 0.030 |
Why?
| | Antibodies, Viral | 1 | 2019 | 624 | 0.030 |
Why?
| | Dental Caries | 1 | 2016 | 155 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 2022 | 0.030 |
Why?
| | Students, Medical | 1 | 2019 | 339 | 0.030 |
Why?
| | Medical History Taking | 1 | 1995 | 117 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2022 | 1772 | 0.030 |
Why?
| | Absorption, Physiological | 1 | 2014 | 4 | 0.030 |
Why?
| | Vaccines, Conjugate | 1 | 2014 | 65 | 0.030 |
Why?
| | Fetal Proteins | 1 | 1994 | 17 | 0.030 |
Why?
| | Insulin-Like Growth Factor II | 1 | 1994 | 22 | 0.030 |
Why?
| | Patient Care Planning | 1 | 2015 | 157 | 0.030 |
Why?
| | Kinetics | 3 | 2007 | 1663 | 0.030 |
Why?
| | Healthcare Disparities | 1 | 2020 | 649 | 0.030 |
Why?
| | Ferrous Compounds | 2 | 2005 | 23 | 0.030 |
Why?
| | Serum Albumin | 3 | 1999 | 150 | 0.030 |
Why?
| | Bacteria | 1 | 2020 | 854 | 0.030 |
Why?
| | Health | 1 | 2014 | 84 | 0.030 |
Why?
| | Tissue Distribution | 1 | 2014 | 330 | 0.030 |
Why?
| | Estradiol | 1 | 1997 | 518 | 0.030 |
Why?
| | Physical Examination | 1 | 1995 | 240 | 0.030 |
Why?
| | Maternal-Fetal Exchange | 1 | 2014 | 165 | 0.030 |
Why?
| | Amino Acids | 1 | 1997 | 497 | 0.030 |
Why?
| | Contraception | 1 | 2015 | 159 | 0.030 |
Why?
| | Uruguay | 1 | 2013 | 2 | 0.030 |
Why?
| | Pregnancy, Twin | 1 | 2013 | 19 | 0.030 |
Why?
| | Morbidity | 1 | 2014 | 323 | 0.020 |
Why?
| | Fetal Mortality | 1 | 2012 | 3 | 0.020 |
Why?
| | Hypertension | 2 | 2016 | 1284 | 0.020 |
Why?
| | Fetal Membranes, Premature Rupture | 1 | 2012 | 37 | 0.020 |
Why?
| | DNA Replication | 1 | 1994 | 238 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2017 | 1044 | 0.020 |
Why?
| | South Australia | 1 | 2011 | 4 | 0.020 |
Why?
| | Healthy Volunteers | 1 | 2012 | 199 | 0.020 |
Why?
| | Mammary Glands, Animal | 1 | 2012 | 129 | 0.020 |
Why?
| | Breath Tests | 1 | 2011 | 87 | 0.020 |
Why?
| | Liver Transplantation | 1 | 1999 | 871 | 0.020 |
Why?
| | Metabolic Diseases | 1 | 2012 | 108 | 0.020 |
Why?
| | Clinical Protocols | 1 | 2012 | 267 | 0.020 |
Why?
| | Sucrose | 1 | 2011 | 110 | 0.020 |
Why?
| | Carbon Isotopes | 1 | 2011 | 144 | 0.020 |
Why?
| | Disease Susceptibility | 1 | 2012 | 345 | 0.020 |
Why?
| | Risk | 1 | 2013 | 908 | 0.020 |
Why?
| | Health Surveys | 1 | 2012 | 513 | 0.020 |
Why?
| | Models, Theoretical | 1 | 2012 | 575 | 0.020 |
Why?
| | Protein Deficiency | 1 | 2007 | 4 | 0.020 |
Why?
| | Biopsy | 1 | 2011 | 1124 | 0.020 |
Why?
| | Lung | 1 | 2020 | 4052 | 0.020 |
Why?
| | Counseling | 1 | 2010 | 388 | 0.020 |
Why?
| | Food, Genetically Modified | 1 | 2006 | 2 | 0.020 |
Why?
| | Self Efficacy | 1 | 2010 | 393 | 0.020 |
Why?
| | Adolescent Nutritional Physiological Phenomena | 1 | 2006 | 27 | 0.020 |
Why?
| | Blood Transfusion | 1 | 1989 | 323 | 0.020 |
Why?
| | Plants, Genetically Modified | 1 | 2006 | 16 | 0.020 |
Why?
| | Biliary Atresia | 1 | 1987 | 163 | 0.020 |
Why?
| | Sweat | 1 | 1986 | 47 | 0.020 |
Why?
| | Asthma | 1 | 2019 | 2282 | 0.010 |
Why?
| | Gallstones | 1 | 2005 | 31 | 0.010 |
Why?
| | Antimalarials | 1 | 2005 | 31 | 0.010 |
Why?
| | Chloroquine | 1 | 2005 | 52 | 0.010 |
Why?
| | Placebos | 1 | 2005 | 199 | 0.010 |
Why?
| | Isotope Labeling | 1 | 2005 | 80 | 0.010 |
Why?
| | Mental Competency | 1 | 2004 | 25 | 0.010 |
Why?
| | Parental Consent | 1 | 2004 | 25 | 0.010 |
Why?
| | Anorexia | 1 | 1984 | 17 | 0.010 |
Why?
| | Family Characteristics | 1 | 2005 | 189 | 0.010 |
Why?
| | Primary Prevention | 1 | 2005 | 196 | 0.010 |
Why?
| | Informed Consent | 1 | 2004 | 172 | 0.010 |
Why?
| | Parent-Child Relations | 1 | 2005 | 268 | 0.010 |
Why?
| | Models, Statistical | 1 | 2007 | 667 | 0.010 |
Why?
| | Gastrointestinal Transit | 1 | 2002 | 6 | 0.010 |
Why?
| | Body Fluid Compartments | 1 | 2002 | 6 | 0.010 |
Why?
| | Mass Screening | 1 | 2010 | 1267 | 0.010 |
Why?
| | Mental Recall | 1 | 2003 | 200 | 0.010 |
Why?
| | Free Radicals | 1 | 2001 | 110 | 0.010 |
Why?
| | Mice | 1 | 2018 | 17733 | 0.010 |
Why?
| | Radioactive Tracers | 1 | 2000 | 3 | 0.010 |
Why?
| | Phosphorus | 1 | 2001 | 97 | 0.010 |
Why?
| | Gastric Mucosa | 1 | 2000 | 55 | 0.010 |
Why?
| | Urine | 1 | 2000 | 56 | 0.010 |
Why?
| | Patient Selection | 1 | 2004 | 690 | 0.010 |
Why?
| | Blood | 1 | 2000 | 107 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2012 | 7585 | 0.010 |
Why?
| | Diabetes Complications | 1 | 2001 | 226 | 0.010 |
Why?
| | Patient Education as Topic | 1 | 2004 | 761 | 0.010 |
Why?
| | Eating | 1 | 2000 | 379 | 0.010 |
Why?
| | Postoperative Period | 1 | 1999 | 342 | 0.010 |
Why?
| | Creatinine | 1 | 1999 | 499 | 0.010 |
Why?
| | Acute Disease | 1 | 1999 | 1004 | 0.010 |
Why?
| | Software | 1 | 2000 | 665 | 0.010 |
Why?
| | North America | 1 | 1995 | 312 | 0.010 |
Why?
| | Europe | 1 | 1995 | 413 | 0.010 |
Why?
| | Chronic Disease | 1 | 1999 | 1784 | 0.010 |
Why?
| | Sheep | 1 | 1994 | 856 | 0.010 |
Why?
| | Erythrocyte Transfusion | 1 | 1989 | 193 | 0.000 |
Why?
| | Urinary Tract Infections | 1 | 1989 | 188 | 0.000 |
Why?
| | Cells, Cultured | 1 | 1994 | 4190 | 0.000 |
Why?
| | RNA, Messenger | 1 | 1994 | 2831 | 0.000 |
Why?
| | Surgical Wound Infection | 1 | 1989 | 305 | 0.000 |
Why?
| | Saliva | 1 | 1983 | 242 | 0.000 |
Why?
| | Blood Proteins | 1 | 1983 | 252 | 0.000 |
Why?
|
|
Krebs's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|